US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

134.79

+0.04000.03%

Post-market: 134.790.00000.00%16:55 EDT

Volume:1.15M

Turnover:154.85M

Market Cap:10.16B

PE:-31.06

High:134.83

Open:134.75

Low:134.71

Close:134.75

52wk High:134.88

52wk Low:35.39

Shares:75.34M

Float Shares:58.14M

Volume Ratio:0.89

T/O Rate:1.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3400

EPS(LYR):-4.2155

ROE:-32.46%

ROA:-20.30%

PB:8.50

PE(LYR):-31.97

Loading ...

Overview Company News Filings

U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys

Apogee Therapeutics to report 16-week Phase 2 APEX data for zumilokibart in atopic dermatitis on May 27

Bank of America Securities Remains a Buy on Apogee Therapeutics (APGE)

Canaccord Genuity Remains a Buy on Apogee Therapeutics (APGE)

Apogee Therapeutics CEO Michael Henderson disposes 20,000 common shares worth $1.64 million

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Apogee Therapeutics (APGE)

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Intellia Therapeutics (NTLA) and Corvus Pharmaceuticals (CRVS)

Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Apogee Therapeutics Q1 EPS $(1.06) Beats $(1.08) Estimate

Benzinga Earnings

Earnings Flash (APGE) Apogee Therapeutics Posts Q1 Net Loss $74.1M, vs. FactSet Est of $74.2M

MT Newswires Live

Apogee Therapeutics Q1 2026 Net Loss $74.11M Vs. Loss Of $55.34M YoY, Cash, Cash Equivalents, Marketable Securities And Long-term Marketable Securities Were $1.3B As Of March 31, 2026, With Cash Runway Into 2029

Benzinga Earnings

Apogee Q1 FY26 net loss widens to $74.1 million

Press Release: Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results

Apogee CMO Carl Dambkowski disposes 5,500 shares worth $465,344.4

Apogee Therapeutics Inc expected to post a loss of $1.10 a share - Earnings Preview

Should Zumilokibart’s Phase 2 Data and Insider Sales Activity Require Action From Apogee Therapeutics (APGE) Investors?

Simply Wall St.

Apogee CFO Jane Henderson disposes of USD 163,206 common shares

Apogee Therapeutics Initiated at Buy by Rothschild & Co

Apogee Therapeutics initiated with a Buy at Rothschild & Co Redburn

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/APGE/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":134.79,"timestamp":1787601600000,"preClose":134.75,"halted":0,"volume":1148993,"hourTrading":{"tag":"盘后","latestPrice":134.79,"preClose":134.79,"latestTime":"16:55 EDT","volume":273148,"amount":36817618.919999994,"timestamp":1787604942252,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00029684601113166636,"floatShares":58137500,"shares":75339900,"eps":-4.34,"marketStatus":"Post-Mkt","change":0.04,"latestTime":"08-24 18:41:00 EDT","open":134.75,"high":134.83,"low":134.71,"amount":154854175.76326,"amplitude":0.000891,"askPrice":135.06,"askSize":226,"bidPrice":134.2,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.34,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":134.75,"preHourTrading":{"tag":"盘前","latestPrice":134.75,"preClose":134.75,"latestTime":"09:29 EDT","volume":90,"amount":12125.6793,"timestamp":1787578199992,"change":0,"changeRate":0,"amplitude":0.0043},"postHourTrading":{"tag":"盘后","latestPrice":134.79,"preClose":134.79,"latestTime":"16:55 EDT","volume":273148,"amount":36817618.919999994,"timestamp":1787604942252,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.887876,"impliedVol":0.0174,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":58137500,"roa":"-20.30%","roe":"-32.46%","lyrEps":-4.215513,"volumeRatio":0.887876,"shares":75339900,"dividePrice":0,"high":134.83,"amplitude":0.000891,"preClose":134.75,"low":134.71,"week52Low":35.39,"pbRate":"8.50","week52High":134.88,"institutionHeld":0,"latestPrice":134.79,"committee":-0.386503,"eps":-4.34,"divideRate":0,"volume":1148993,"delay":0,"ttmEps":-4.34,"open":134.75,"prevYearClose":75.48,"prevWeekClose":134.75,"prevMonthClose":134.09,"prevQuarterClose":132.73,"fiveDayClose":134.59,"twentyDayClose":134.28,"sixtyDayClose":77.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"APGE","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-1.14},{"market":"US","date":"2026-05-11","symbol":"APGE","fiscalQuarterEnding":"2026/03","expectedEps":-1.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2026-03-02","symbol":"APGE","fiscalQuarterEnding":"2025/12","expectedEps":-1.05,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-11-10","symbol":"APGE","fiscalQuarterEnding":"2025/09","expectedEps":-1.14,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.11},{"market":"US","date":"2025-08-11","symbol":"APGE","fiscalQuarterEnding":"2025/06","expectedEps":-1.03,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.0667,"hold":0.9333,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9333,"analysts":15,"updateTime":1786593600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2026-08-21","current":-31.048387,"percent":0.092715,"low":-42.099968,"twenty":-25.999346,"median":-19.423136,"eighty":-12.51704,"high":-8.51736,"avg":-20.424875,"sd":8.051869,"marketCap":10162217065},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600},{"date":"2025-06-13","current":-11.895942,"twenty":-26.656227,"median":-20.052494,"eighty":-12.887608,"marketCap":2443319391},{"date":"2025-06-20","current":-11.702697,"twenty":-26.554695,"median":-19.987224,"eighty":-12.832982,"marketCap":2403628584},{"date":"2025-06-27","current":-12.450101,"twenty":-26.451682,"median":-19.588347,"eighty":-12.738391,"marketCap":2557138617},{"date":"2025-07-03","current":-13.487372,"twenty":-26.404333,"median":-19.162534,"eighty":-12.723904,"marketCap":2770184861},{"date":"2025-07-11","current":-10.960977,"twenty":-26.318444,"median":-18.921984,"eighty":-12.668332,"marketCap":2251285927},{"date":"2025-07-18","current":-11.083176,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"marketCap":2276384526},{"date":"2025-07-25","current":-11.833421,"twenty":-26.172746,"median":-18.534,"eighty":-12.51704,"marketCap":2430478247},{"date":"2025-08-01","current":-10.872879,"twenty":-26.165436,"median":-18.435064,"eighty":-12.454858,"marketCap":2233191588},{"date":"2025-08-08","current":-10.230624,"twenty":-26.144692,"median":-18.356106,"eighty":-12.348931,"marketCap":2101278024},{"date":"2025-08-15","current":-9.370325,"twenty":-26.131061,"median":-18.310909,"eighty":-12.239332,"marketCap":2227054492},{"date":"2025-08-22","current":-8.957767,"twenty":-26.099427,"median":-18.29345,"eighty":-12.125473,"marketCap":2129001470},{"date":"2025-08-29","current":-9.024303,"twenty":-26.061716,"median":-18.235984,"eighty":-12.057962,"marketCap":2144815236},{"date":"2025-09-05","current":-9.149983,"twenty":-26.050112,"median":-18.048125,"eighty":-11.971712,"marketCap":2174685683},{"date":"2025-09-12","current":-9.184484,"twenty":-25.999346,"median":-17.978348,"eighty":-11.914309,"marketCap":2182885414},{"date":"2025-09-19","current":-9.470344,"twenty":-25.989488,"median":-17.837569,"eighty":-11.833421,"marketCap":2250826038},{"date":"2025-09-26","current":-9.246091,"twenty":-25.963085,"median":-17.587319,"eighty":-11.751667,"marketCap":2197527790},{"date":"2025-10-03","current":-9.761132,"twenty":-25.927394,"median":-17.537558,"eighty":-11.64586,"marketCap":2319938053},{"date":"2025-10-10","current":-13.112594,"twenty":-25.927394,"median":-17.474803,"eighty":-11.60039,"marketCap":3116483307},{"date":"2025-10-17","current":-14.719201,"twenty":-25.919571,"median":-17.381927,"eighty":-11.6264,"marketCap":3498327236},{"date":"2025-10-24","current":-14.83497,"twenty":-25.825784,"median":-17.31961,"eighty":-11.641401,"marketCap":3525842169},{"date":"2025-10-31","current":-15.446892,"twenty":-25.767274,"median":-17.151542,"eighty":-11.64586,"marketCap":3671278245},{"date":"2025-11-07","current":-15.158848,"twenty":-25.763689,"median":-17.013102,"eighty":-11.649617,"marketCap":3602818471},{"date":"2025-11-14","current":-16.75274,"twenty":-25.752769,"median":-16.901067,"eighty":-11.702697,"marketCap":4249734472},{"date":"2025-11-21","current":-16.859157,"twenty":-25.643182,"median":-16.952708,"eighty":-11.751008,"marketCap":4276729768},{"date":"2025-11-28","current":-19.147128,"twenty":-25.58,"median":-17.00282,"eighty":-11.751535,"marketCap":4857128632},{"date":"2025-12-05","current":-20.086261,"twenty":-25.516057,"median":-17.081704,"eighty":-11.751783,"marketCap":5095362120},{"date":"2025-12-12","current":-20.360285,"twenty":-25.476749,"median":-17.24758,"eighty":-11.795704,"marketCap":5164875007},{"date":"2025-12-19","current":-20.578441,"twenty":-25.464129,"median":-17.327965,"eighty":-11.813694,"marketCap":5220215364},{"date":"2025-12-26","current":-20.775313,"twenty":-25.437705,"median":-17.381927,"eighty":-11.826232,"marketCap":5270156661},{"date":"2026-01-02","current":-20.08094,"twenty":-25.407235,"median":-17.443781,"eighty":-11.835695,"marketCap":5094012355},{"date":"2026-01-09","current":-20.613026,"twenty":-25.376631,"median":-17.517481,"eighty":-11.841525,"marketCap":5228988835},{"date":"2026-01-16","current":-21.482988,"twenty":-25.344147,"median":-17.566657,"eighty":-11.865469,"marketCap":5449675380},{"date":"2026-01-23","current":-21.246209,"twenty":-25.316184,"median":-17.607671,"eighty":-11.899615,"marketCap":5389610846},{"date":"2026-01-30","current":-18.617702,"twenty":-25.310382,"median":-17.773551,"eighty":-11.916319,"marketCap":4722827035},{"date":"2026-02-06","current":-16.529263,"twenty":-25.299938,"median":-17.629714,"eighty":-11.92777,"marketCap":4193044351},{"date":"2026-02-13","current":-18.439453,"twenty":-25.257004,"median":-17.587319,"eighty":-11.943328,"marketCap":4677609914},{"date":"2026-02-20","current":-18.338357,"twenty":-25.252364,"median":-17.631406,"eighty":-11.950995,"marketCap":4651964383},{"date":"2026-02-27","current":-18.380924,"twenty":-25.237859,"median":-17.924865,"eighty":-11.971712,"marketCap":4662762501},{"date":"2026-03-06","current":-19.084656,"twenty":-25.237859,"median":-18.011929,"eighty":-12.048249,"marketCap":4882675550},{"date":"2026-03-13","current":-19.781628,"twenty":-25.201598,"median":-18.048125,"eighty":-12.051438,"marketCap":5060990972},{"date":"2026-03-20","current":-18.433431,"twenty":-25.17554,"median":-18.05103,"eighty":-12.057816,"marketCap":4716064230},{"date":"2026-03-27","current":-22.635495,"twenty":-25.092814,"median":-18.211825,"eighty":-12.058545,"marketCap":5791132948},{"date":"2026-04-02","current":-24.315405,"twenty":-25.034796,"median":-18.255434,"eighty":-12.060324,"marketCap":6220926288},{"date":"2026-04-10","current":-24.973515,"twenty":-25.014384,"median":-18.297329,"eighty":-12.063509,"marketCap":6389298937},{"date":"2026-04-17","current":-26.136752,"twenty":-25.109359,"median":-18.322222,"eighty":-12.100103,"marketCap":6686904979},{"date":"2026-04-24","current":-25.484415,"twenty":-25.24076,"median":-18.338357,"eighty":-12.174653,"marketCap":6520009283},{"date":"2026-05-01","current":-23.925736,"twenty":-25.237859,"median":-18.357757,"eighty":-12.211865,"marketCap":6121231957},{"date":"2026-05-08","current":-23.887288,"twenty":-25.20885,"median":-18.380924,"eighty":-12.222332,"marketCap":6111395326},{"date":"2026-05-15","current":-22.900754,"twenty":-25.180752,"median":-18.433431,"eighty":-12.226576,"marketCap":6288890455},{"date":"2026-05-22","current":-22.496831,"twenty":-25.109359,"median":-18.46514,"eighty":-12.275404,"marketCap":6177967349},{"date":"2026-05-29","current":-21.238668,"twenty":-25.059336,"median":-18.527248,"eighty":-12.293604,"marketCap":5832456861},{"date":"2026-06-05","current":-24.808467,"twenty":-25.026981,"median":-18.566539,"eighty":-12.31583,"marketCap":6812777290},{"date":"2026-06-12","current":-24.426379,"twenty":-25.015861,"median":-18.628344,"eighty":-12.336427,"marketCap":6707850027},{"date":"2026-06-18","current":-24.134354,"twenty":-25.012907,"median":-18.658155,"eighty":-12.355752,"marketCap":6627655619},{"date":"2026-06-26","current":-36.211083,"twenty":-25.070495,"median":-18.735668,"eighty":-12.378968,"marketCap":9944106610},{"date":"2026-07-02","current":-36.235646,"twenty":-25.230607,"median":-18.783693,"eighty":-12.388203,"marketCap":9950851934},{"date":"2026-07-10","current":-36.453982,"twenty":-25.299938,"median":-18.859802,"eighty":-12.416911,"marketCap":10010810370},{"date":"2026-07-17","current":-36.593172,"twenty":-25.381567,"median":-18.941441,"eighty":-12.454858,"marketCap":10049033873},{"date":"2026-07-24","current":-36.706227,"twenty":-25.481518,"median":-19.08331,"eighty":-12.473884,"marketCap":10080080493},{"date":"2026-07-31","current":-36.717163,"twenty":-25.564204,"median":-19.092697,"eighty":-12.473884,"marketCap":10083083645},{"date":"2026-08-07","current":-36.769108,"twenty":-25.767274,"median":-19.147128,"eighty":-12.501095,"marketCap":10097348618},{"date":"2026-08-14","current":-34.444709,"twenty":-25.927394,"median":-19.256206,"eighty":-12.51704,"marketCap":10139592463},{"date":"2026-08-21","current":-34.521566,"twenty":-25.999346,"median":-19.423136,"eighty":-12.51704,"marketCap":10162217065}],"updateTime":1787576899790},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638168895","title":"U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys","url":"https://stock-news.laohu8.com/highlight/detail?id=2638168895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638168895?lang=en_us&edition=fundamental","pubTime":"2026-05-27 16:06","pubTimestamp":1779869170,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, SynopsysMay 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agile","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nL4N4240LW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZS","KNX","AMAT","CNC","AAL","SNPS","SKY","AZO","BXP","PALD","CRC","APLD","CNCG","GE","APLX","ALHC","IPSC","LRMR","AALG","CVX","CDNS","PTC","A","ET","VICR","ACNB","IE0031619046.USD","AGCO","PANG","PODD","VRRM","ELF","CRK","ASTH","PANW","ALK","APGE","SMTC","CI","PALU","APLZ","AR","APA","BURL","AGL","LU2063271972.USD","SNPX","LW","MO","FDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638396540","title":"Apogee Therapeutics to report 16-week Phase 2 APEX data for zumilokibart in atopic dermatitis on May 27","url":"https://stock-news.laohu8.com/highlight/detail?id=2638396540","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638396540?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:01","pubTimestamp":1779825694,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics scheduled release of Part B 16-week results from the Phase 2 APEX trial of zumilokibart in moderate-to-severe atopic dermatitis.Data will be presented on May 27, 2026, followed by an 8:00 a.m. ET conference call and webcast.Zumilokibart is Apogee’s lead biologic program, positioned as a potential best-in-class therapy with less frequent dosing in large inflammation markets.The readout is a key near-term catalyst for the company’s atopic dermatitis strategy, with additional development planned in asthma and eosinophilic esophagitis.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL33mvQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BKPKM429.USD","LU2095319765.USD","IE00B64PRP62.GBP","LU0053671581.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","SG9999014039.USD","LU2210150020.SGD","BK4112","SG9999014005.SGD","APGE","BK4585","NDAQ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637339721","title":"Bank of America Securities Remains a Buy on Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637339721","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637339721?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:18","pubTimestamp":1779441528,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Apogee Therapeutics yesterday and set a price target of $131.00. The com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","LU2133065610.SGD","LU1718418525.SGD","BK4504","LU0130518102.USD","LU0211331839.USD","IE00BKVL7J92.USD","LU1035773651.USD","BK4534","BK4581","BK4588","LU1366192091.USD","LU0203347892.USD","LU0971096721.USD","LU0106831901.USD","IE0001KFT4U8.USD","LU1201861165.SGD","LU2129689514.USD","LU0053671581.USD","LU0053666078.USD","LU0640476718.USD","LU0310800965.SGD","LU0256863811.USD","LU1496350171.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","IE00B7SZLL34.SGD","LU1791807156.HKD","LU0320765646.SGD","LU0052756011.USD","BK4582","LU0130517989.USD","LU0320765489.SGD","LU0980610538.SGD","IE00BFXG1179.USD","BAC","APGE","IE00B1BXHZ80.USD","LU1894683348.USD","LU1506573853.SGD","BK4207","LU1201861249.SGD","LU0648001328.SGD","LU0787776722.HKD","LU1069347547.HKD","LU0314106906.USD","LU0130102774.USD","LU1804176565.USD","LU2129689605.HKD","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637633837","title":"Canaccord Genuity Remains a Buy on Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637633837","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637633837?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:16","pubTimestamp":1779362177,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Edward Nash maintained a Buy rating on Apogee Therapeutics today and set a price target of $130.00. According to TipRanks...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-remains-a-buy-on-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635056156","title":"Apogee Therapeutics CEO Michael Henderson disposes 20,000 common shares worth $1.64 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635056156","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635056156?lang=en_us&edition=fundamental","pubTime":"2026-05-16 08:00","pubTimestamp":1778889648,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics CEO Michael Thomas Henderson sold 20,000 shares on May 13, 2026.Sales priced at USD 82.05 per share for 18,659 shares, USD 82.58 per share for 1,341 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260516:nNDL965r15:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CEO Michael Henderson disposes 20,000 common shares worth $1.64 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635358799","title":"U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2635358799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635358799?lang=en_us&edition=fundamental","pubTime":"2026-05-14 15:24","pubTimestamp":1778743446,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cisc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4N41R0NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRVU","APGE","DELL","CSR","CIFG","AFRM","AVTX","BXP","CVNX","CPT","CMC","ASO","CMP","CAVA","DTE","AVB","CIFR","CMS","DMRA","CSCL","DOCS","DECK","CAKE","CVNY","CIFU","AEE","ATLC","CSCO","AFRU","ANTX","AMGN","CLH","AN","ET","ANDG","MRVL","CARR","CORZ","CSCS","DLLL","EBAY","MVLL","CGON","ARMK","AKAM","ARVN","ASTH","CVNA","DT","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634176592","title":"Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Apogee Therapeutics (APGE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634176592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634176592?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:31","pubTimestamp":1778592661,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Oculis Holding (OCS) and Apogee Therapeutics (APGE). Oculis Holdi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oculis-holding-ocs-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oculis-holding-ocs-and-apogee-therapeutics-apge-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","XLV","LU0053671581.USD","APGE","BK4139","LABU","LU0128526141.USD","XBI","BK4581","BK4137","BK4007","HCSG","OCS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634123312","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Intellia Therapeutics (NTLA) and Corvus Pharmaceuticals (CRVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634123312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634123312?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:40","pubTimestamp":1778514014,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apogee Therapeutics (APGE), Intellia Therapeutics (N...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-intellia-therapeutics-ntla-and-corvus-pharmaceuticals-crvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-intellia-therapeutics-ntla-and-corvus-pharmaceuticals-crvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","CRVS","NTLA","LU0029874061.USD","LU1861559042.SGD","BK4137","BK4568","XLV","XBI","BK4585","LU0128526141.USD","BK4588","BK4556","LU0053671581.USD","BK4535","BK4139","LABU","APGE","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634282977","title":"Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634282977","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634282977?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:31","pubTimestamp":1778506268,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryApogee Therapeutics Inc APGE.OQ reported a quarterly adjusted loss of $1.06 per share for the quarter ended Mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O1FJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634285155","title":"Apogee Therapeutics Q1 EPS $(1.06) Beats $(1.08) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634285155","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634285155?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:38","pubTimestamp":1778499538,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(1.08) by 1.85 percent. This is a 11.58 percent decrease over losses of $(0.95) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52443738/apogee-therapeutics-q1-eps-1-06-beats-1-08-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634831202","title":"Earnings Flash (APGE) Apogee Therapeutics Posts Q1 Net Loss $74.1M, vs. FactSet Est of $74.2M","url":"https://stock-news.laohu8.com/highlight/detail?id=2634831202","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634831202?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:16","pubTimestamp":1778498182,"startTime":"0","endTime":"0","summary":"Earnings Flash (APGE) Apogee Therapeutics Posts Q1 Net Loss $74.1M, vs. FactSet Est of $74.2M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634971283","title":"Apogee Therapeutics Q1 2026 Net Loss $74.11M Vs. Loss Of $55.34M YoY, Cash, Cash Equivalents, Marketable Securities And Long-term Marketable Securities Were $1.3B As Of March 31, 2026, With Cash Runway Into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2634971283","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634971283?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:14","pubTimestamp":1778498086,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics Q1 2026 Net Loss $74.11M Vs. Loss Of $55.34M YoY, Cash, Cash Equivalents, Marketable Securities And Long-term Marketable Securities Were $1.3B As Of March 31, 2026, With Cash Runway Into 2029","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/APGE","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288047","title":"Apogee Q1 FY26 net loss widens to $74.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634288047?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:03","pubTimestamp":1778497408,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics posted a net loss of USD 74.1 million for first-quarter 2026, widening from USD 55.3 million a year earlier.Operating loss widened to USD 82.8 million from USD 63.1 million, as R&D expenses climbed to USD 60.8 million from USD 46.4 million.G&A costs increased to USD 22 million from USD 16.7 million, while interest income rose to USD 8.7 million from USD 7.8 million.Cash, cash equivalents and marketable securities totaled USD 1.3 billion at March 31, up from USD 902.9 million at Dec. 31, after an upsized USD 403 million public equity offering; runway forecast into 2029.APEX Phase 2 Part B 16-week data for zumilokibart in atopic dermatitis expected in Q2 2026, with Phase 3 initiation planned for the second half of 2026 and additional asthma and eosinophilic esophagitis trial details due later this year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLbg3KlF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","LU2210149790.SGD","NDAQ","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4585","BK4112","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","LU0053671581.USD","BK4139","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","APGE","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634928808","title":"Press Release: Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634928808","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634928808?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:01","pubTimestamp":1778497260,"startTime":"0","endTime":"0","summary":"Zumilokibart advancing across multiple indications, with Phase 3 initiation in atopic dermatitis  expected later this year:. - APEX Phase 2 Part A 52-week data demonstrated durable maintenance and improved efficacy over time with every 3- and 6-month dosing in moderate-to-severe AD. - APEX Phase 2 Part B 16-week data in AD expected in Q2 2026. - Following positive Phase 1b asthma results earlier this year, expansion plans are underway with additional trial details for asthma and eosinophilic esophagitis  expected later this year. Strong cash position of $1.3B following successful public equity offering extending runway into 2029, through planned BLA filing for AD, subject to regulatory alignment. SAN FRANCISCO and BOSTON, May 11, 2026  -- Apogee Therapeutics, Inc. , a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today provided pipeline progress and report","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4132","AD","BK4097","LU2065732104.USD","PRGS","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634493935","title":"Apogee CMO Carl Dambkowski disposes 5,500 shares worth $465,344.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2634493935","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634493935?lang=en_us&edition=fundamental","pubTime":"2026-05-09 08:01","pubTimestamp":1778284895,"startTime":"0","endTime":"0","summary":"Carl Dambkowski, Chief Medical Officer, sold 5,500 shares of Apogee Therapeutics common stock on May 6, 2026 at weighted average prices of USD 83.92 and USD 84.6.He exercised stock options for 4,125 shares at USD 22.86 in the same session.Beneficial ownership stood at 207,023 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260509:nNDL8TCqnq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Apogee CMO Carl Dambkowski disposes 5,500 shares worth $465,344.4","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468329","title":"Apogee Therapeutics Inc  expected to post a loss of $1.10 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468329","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468329?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:30","pubTimestamp":1778254243,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics Inc  expected to post a loss of $1.10 a share - Earnings Preview Apogee Therapeutics Inc APGE.OQ APGE.O is expected to  show no change in quarterly revenue when it reports  results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1V3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633609993","title":"Should Zumilokibart’s Phase 2 Data and Insider Sales Activity Require Action From Apogee Therapeutics (APGE) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2633609993","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633609993?lang=en_us&edition=fundamental","pubTime":"2026-05-05 10:22","pubTimestamp":1777947764,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics recently reported promising Phase 2 trial results for its lead drug candidate zumilokibart in atopic dermatitis, alongside new bullish analyst coverage that highlighted the therapy’s potential for very infrequent dosing.\nInsider Jane Henderson also disclosed multiple pre-planned sales of restricted stock earlier this year, underscoring how management is gradually monetizing prior equity awards while clinical data raise the company’s profile.\nWe’ll now examine how the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-apge/apogee-therapeutics/news/should-zumilokibarts-phase-2-data-and-insider-sales-activity","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-apge/apogee-therapeutics/news/should-zumilokibarts-phase-2-data-and-insider-sales-activity","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633967261","title":"Apogee CFO Jane Henderson disposes of USD 163,206 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2633967261","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633967261?lang=en_us&edition=fundamental","pubTime":"2026-05-05 08:00","pubTimestamp":1777939248,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics CFO Jane Pritchett Henderson reported sale of 2,000 common shares on May 1, 2026 at weighted average prices of USD 81.02, USD 82.6, USD 83.16.Holdings fell to 173,371 common shares following transactions.Sales were executed under a Rule 10b5-1 trading plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL4ZJDfk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee CFO Jane Henderson disposes of USD 163,206 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632148736","title":"Apogee Therapeutics Initiated at Buy by Rothschild & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2632148736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632148736?lang=en_us&edition=fundamental","pubTime":"2026-05-01 20:02","pubTimestamp":1777636920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 01, 2026 08:02 ET (12:02 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632613316","title":"Apogee Therapeutics initiated with a Buy at Rothschild & Co Redburn","url":"https://stock-news.laohu8.com/highlight/detail?id=2632613316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632613316?lang=en_us&edition=fundamental","pubTime":"2026-05-01 16:45","pubTimestamp":1777625128,"startTime":"0","endTime":"0","summary":"Rothschild & Co Redburn analyst Qize Ding initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $140 price target The firm has a “...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-initiated-with-a-buy-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-initiated-with-a-buy-at-rothschild-co-redburn-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":197,"code":"91000000","status":"200"}]}}